Abstract |
Phosphodiesterase inhibitors have been reported to be beneficial in cognitive and motor disorders. In the present study, we have investigated the effects of RO 20-1724 ( PDE4 inhibitor) and sildenafil ( PDE5 inhibitor) in 3-nitropropionic acid (3-NP) induced experimental Huntington's disease in rats. 3-Nitropropionic acid was administered for 14 days (10 mg/kg i.p.) 1h following 3-NP administration, the rats were treated with either vehicle, RO 20-1724 (0.25 and 0.5 mg/kg i.p.) or sildenafil (2 and 4 mg/kg i.p.) for 14 days. Cognitive functions were assessed by using Morris water maze whereas, motor functions were assessed by spontaneous locomotor activity, limb withdrawal and suspended wire test at different time points. Biochemically, markers of oxidative stress and cell damage, such as reduced glutathione, malondialdehyde, nitrite and lactate dehydrogenase levels were assessed terminally in the brain homogenate. Chronic administration of 3-NP produced significant decrease in body weight, showed marked abnormalities in cognitive and motor functions. Further, significant oxidative-nitrosative stress and cell damage was also observed. Chronic administration of RO 20-1724 and sildenafil in 3-NP treated rats significantly and dose dependently attenuated 3-NP induced behavioral and biochemical abnormalities in rats. Both these drugs were equally effective in attenuating 3-NP induced neurotoxicity. These results suggesting that the inhibition of PDE4 and PDE5 would be therapeutic in neurodegenerative disorders associated with cognitive and motor dysfunction.
|
Authors | Tarun Thakur, Sorabh Sharma, Kushal Kumar, Rahul Deshmukh, Pyare Lal Sharma |
Journal | European journal of pharmacology
(Eur J Pharmacol)
Vol. 714
Issue 1-3
Pg. 515-21
(Aug 15 2013)
ISSN: 1879-0712 [Electronic] Netherlands |
PMID | 23831390
(Publication Type: Journal Article)
|
Copyright | © 2013 Elsevier B.V. All rights reserved. |
Chemical References |
- Neuroprotective Agents
- Nitro Compounds
- Phosphodiesterase 4 Inhibitors
- Phosphodiesterase 5 Inhibitors
- Piperazines
- Propionates
- Purines
- Sulfones
- 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone
- Malondialdehyde
- Sildenafil Citrate
- L-Lactate Dehydrogenase
- Succinate Dehydrogenase
- Glutathione
- 3-nitropropionic acid
|
Topics |
- 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone
(pharmacology)
- Animals
- Behavior, Animal
(drug effects)
- Body Weight
(drug effects)
- Brain
(drug effects, enzymology, metabolism)
- Glutathione
(metabolism)
- L-Lactate Dehydrogenase
(metabolism)
- Malondialdehyde
(metabolism)
- Maze Learning
(drug effects, physiology)
- Memory
(drug effects)
- Neuroprotective Agents
(pharmacology)
- Nitro Compounds
(toxicity)
- Phosphodiesterase 4 Inhibitors
(pharmacology)
- Phosphodiesterase 5 Inhibitors
(pharmacology)
- Piperazines
(pharmacology)
- Propionates
(toxicity)
- Purines
(pharmacology)
- Rats
- Rats, Wistar
- Sildenafil Citrate
- Succinate Dehydrogenase
(metabolism)
- Sulfones
(pharmacology)
|